Literature DB >> 9165044

Cyclic adenosine 3',5'-monophosphate regulates GLUT4 and GLUT1 glucose transporter expression and stimulates transcriptional activity of the GLUT1 promoter in muscle cells.

F Viñals1, J Ferré, C Fandos, T Santalucia, X Testar, M Palacín, A Zorzano.   

Abstract

We have previously reported that innervation-dependent basal contractile activity regulates in an inverse manner the expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle. Based on the facts that muscle innervation decreases and muscle denervation increases cAMP levels, we investigated whether cAMP might mediate the effects of innervation/denervation on glucose transporter expression. Treatment of L6E9 myotubes with 8-bromo-cAMP, forskolin, or monobutyryl-8-bromo-cAMP led to a marked decrease in GLUT4 protein levels; 8-bromo-cAMP also diminished GLUT4 messenger RNA (mRNA), suggesting pretranslational repression. In contrast, L6E9 myoblasts and myotubes responded to 8-bromo-cAMP or forskolin by increasing the cell content of GLUT1 protein. Induction of GLUT1 protein was a consequence of the activation of different mechanisms in myoblast and myotube cells; whereas 8-bromo-cAMP treatment caused a substantial increase in GLUT1 mRNA in myoblasts, no change in GLUT1 mRNA was detected in myotubes. The increase in GLUT1 mRNA in L6E9 myoblasts induced by 8-bromo-cAMP was the result of transcriptional activation, as concluded from transfection analysis of 2.1 kilobases of the rat GLUT1 gene promoter fused to the bacterial chloramphenicol acetyltransferase gene. Furthermore, the stimulatory effect of 8-bromo-cAMP on the transcriptional activity of the GLUT1 promoter required a 33-bp sequence lying 5' upstream of the transcription start site. In all, cAMP inversely regulates GLUT4 and GLUT1 glucose transporter expression in muscle cells. Furthermore, our results suggest that down-regulation of GLUT4 expression and up-regulation of GLUT1 expression in muscle associated with denervation are partly attributable to cAMP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9165044     DOI: 10.1210/endo.138.6.5217

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells.

Authors:  Julia Nevzorova; Bronwyn A Evans; Tore Bengtsson; Roger J Summers
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

2.  Insulin and insulin-like growth factor I up-regulate GLUT4 gene expression in fetal brown adipocytes, in a phosphoinositide 3-kinase-dependent manner.

Authors:  A M Valverde; P Navarro; T Teruel; R Conejo; M Benito; M Lorenzo
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling.

Authors:  F Viñals; J Pouysségur
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

4.  Insulin and dexamethasone induce GLUT4 gene expression in foetal brown adipocytes: synergistic effect through CCAAT/enhancer-binding protein alpha.

Authors:  Rosario Hernandez; Teresa Teruel; Margarita Lorenzo
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

5.  Hypoxia increases glucose transporter 1 expression in bovine corpus luteum at the early luteal stage.

Authors:  Ryo Nishimura; Hiroki Hasegawa; Masamichi Yamashita; Norihiko Ito; Yoshiharu Okamoto; Takashi Takeuchi; Tomoaki Kubo; Kosuke Iga; Koji Kimura; Mitsugu Hishinuma; Kiyoshi Okuda
Journal:  J Vet Med Sci       Date:  2017-10-17       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.